Education
About Us
Working with TipRanks
Follow Us
Actinium Pharmaceuticals (DE:7AY1)
FRANKFURT:7AY1
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 81.00K | $ 1.03M | $ 1.14M | $ 0.00 |
| Gross Profit | $ 0.00 | $ 81.00K | $ 331.00K | $ 620.00K | $ -447.00K |
| Operating Income | $ -42.12M | $ -51.92M | $ -34.10M | $ -24.96M | $ -22.39M |
| EBITDA | $ -37.43M | $ -51.13M | $ -33.41M | $ -24.44M | $ -21.77M |
| Net Income | $ -38.24M | $ -48.82M | $ -31.93M | $ -24.58M | $ -22.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 72.90M | $ 76.68M | $ 108.91M | $ 77.83M | $ 63.56M |
| Total Assets | $ 76.90M | $ 81.44M | $ 114.19M | $ 80.39M | $ 66.40M |
| Total Debt | $ 1.57M | $ 2.11M | $ 2.58M | $ 310.00K | $ 738.00K |
| Net Debt | $ -71.33M | $ -74.56M | $ -106.33M | $ -77.52M | $ -62.82M |
| Total Liabilities | $ 44.14M | $ 45.07M | $ 47.71M | $ 6.84M | $ 5.08M |
| Stockholders' Equity | $ 32.76M | $ 36.38M | $ 66.48M | $ 73.55M | $ 61.32M |
| Cash Flow | |||||
| Free Cash Flow | $ -33.08M | $ -47.49M | $ 8.28M | $ -21.00M | $ -21.87M |
| Operating Cash Flow | $ -33.07M | $ -47.34M | $ 8.64M | $ -20.87M | $ -21.62M |
| Investing Cash Flow | $ -11.00K | $ -153.00K | $ -366.00K | $ -133.00K | $ -253.00K |
| Financing Cash Flow | $ 29.32M | $ 14.87M | $ 23.11M | $ 35.22M | $ 76.18M |